Genetic and stochastic influences on the interaction of human immunodeficiency virus type 1 and cytotoxic T lymphocytes in identical twins.

Otto O Yang, Joseph Church, Christina M R Kitchen, Ryan Kilpatrick, Ayub Ali, Yongzhi Geng, M Scott Killian, Rachel Lubong Sabado, Hwee Ng, Jeffrey Suen, Yvonne Bryson, Beth D Jamieson, Paul Krogstad
Author Information
  1. Otto O Yang: UCLA AIDS Institute and Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California 90095, USA. oyang@mednet.ucla.edu

Abstract

Human immunodeficiency virus type 1 (HIV-1) evolves in vivo under selective pressure from CD8+ T-lymphocyte (CTL) responses, which are in turn determined by host and viral genetic factors, such as restricting major histocompatibility complex molecules and the available viral epitope sequences. However, CTL are derived stochastically through the random gene rearrangements to produce T-cell receptors (TCR), and the relative impact of genetic versus stochastic processes on CTL targeting of HIV and immune-driven viral evolution is unclear. Here we evaluate identical twins infected with HIV-1 as neonates from a common blood transfusion, with subsequently similar environmental exposures, thereby allowing controlled comparisons of CTL targeting and viral evolution. Seventeen years after infection, their CTL targeting of HIV-1 was remarkably similar. In contrast, their overall TCR profiles were highly dissimilar, and a dominant epitope was recognized by distinctly different TCR in each twin. Furthermore, their viral epitopes had diverged, and there was ongoing viral phylogenetic divergence between the twins between 12 and 17 years after infection. These results indicate that while CTL targeting is predominately genetically determined, stochastic influences render the interaction of HIV-1 and host immunity, and therefore viral escape and CTL efficacy, unpredictable.

References

  1. J Virol. 1998 Jan;72(1):164-9 [PMID: 9420212]
  2. Annu Rev Immunol. 1997;15:271-96 [PMID: 9143689]
  3. Science. 1999 Feb 5;283(5403):857-60 [PMID: 9933172]
  4. J Exp Med. 1999 Mar 15;189(6):991-8 [PMID: 10075982]
  5. Bioinformatics. 2000 Apr;16(4):400-1 [PMID: 10869039]
  6. J Virol. 2000 Oct;74(19):9144-51 [PMID: 10982361]
  7. Microbiol Mol Biol Rev. 2001 Mar;65(1):151-85 [PMID: 11238990]
  8. J Virol. 2001 Jul;75(14):6279-91 [PMID: 11413294]
  9. Nature. 2002 Jan 17;415(6869):335-9 [PMID: 11797012]
  10. J Immunol. 2002 Mar 15;168(6):3099-104 [PMID: 11884484]
  11. AIDS Res Hum Retroviruses. 2002 Apr 10;18(6):413-7 [PMID: 11958684]
  12. Science. 2002 May 24;296(5572):1439-43 [PMID: 12029127]
  13. Clin Diagn Lab Immunol. 2002 Jul;9(4):858-63 [PMID: 12093686]
  14. J Infect Dis. 2002 Jul 15;186(2):281-5 [PMID: 12134267]
  15. AIDS Res Hum Retroviruses. 2002 Sep 20;18(14):1051-65 [PMID: 12396457]
  16. Nature. 2002 Nov 28;420(6914):434-9 [PMID: 12459786]
  17. Trends Immunol. 2003 Feb;24(2):67-72 [PMID: 12547502]
  18. Clin Diagn Lab Immunol. 2003 Mar;10(2):323-8 [PMID: 12626462]
  19. J Exp Med. 2003 May 19;197(10):1365-75 [PMID: 12743169]
  20. Syst Biol. 2003 Oct;52(5):649-64 [PMID: 14530132]
  21. Trends Immunol. 2004 Mar;25(3):138-42 [PMID: 15036041]
  22. J Virol. 2004 Oct;78(20):11296-302 [PMID: 15452249]
  23. Nature. 1987 Jul 23-29;328(6128):345-8 [PMID: 3496541]
  24. Science. 1993 Nov 19;262(5137):1257-61 [PMID: 8235655]
  25. J Virol. 1994 Jul;68(7):4650-5 [PMID: 8207839]
  26. J Virol. 1994 Sep;68(9):6103-10 [PMID: 8057491]
  27. Nature. 1995 Jan 12;373(6510):117-22 [PMID: 7529365]
  28. Nature. 1995 Jan 12;373(6510):123-6 [PMID: 7816094]
  29. Science. 1995 Jan 27;267(5197):483-9 [PMID: 7824947]
  30. J Virol. 1995 Aug;69(8):5087-94 [PMID: 7541846]
  31. J Virol. 1995 Dec;69(12):8142-6 [PMID: 7494338]
  32. J Virol. 1997 Apr;71(4):3120-8 [PMID: 9060675]
  33. AIDS. 1997 Mar 15;11(4):415-22 [PMID: 9084787]
  34. AIDS. 1997;11 Suppl A:S17-24 [PMID: 9451962]

Grants

  1. AI043203/NIAID NIH HHS
  2. R01 AI051996/NIAID NIH HHS
  3. P30 AI028697/NIAID NIH HHS
  4. AI028697/NIAID NIH HHS
  5. R01 AI043203/NIAID NIH HHS

MeSH Term

Acquired Immunodeficiency Syndrome
HIV Seropositivity
HIV-1
Humans
Immunodominant Epitopes
T-Lymphocytes, Cytotoxic
Twins

Chemicals

Immunodominant Epitopes

Word Cloud

Created with Highcharts 10.0.0CTLviralHIV-1targetingTCRstochastictwinsimmunodeficiencyvirustype1determinedhostgeneticepitopeevolutionidenticalsimilaryearsinfectioninfluencesinteractionHumanevolvesvivoselectivepressureCD8+T-lymphocyteresponsesturnfactorsrestrictingmajorhistocompatibilitycomplexmoleculesavailablesequencesHoweverderivedstochasticallyrandomgenerearrangementsproduceT-cellreceptorsrelativeimpactversusprocessesHIVimmune-drivenunclearevaluateinfectedneonatescommonbloodtransfusionsubsequentlyenvironmentalexposurestherebyallowingcontrolledcomparisonsSeventeenremarkablycontrastoverallprofileshighlydissimilardominantrecognizeddistinctlydifferenttwinFurthermoreepitopesdivergedongoingphylogeneticdivergence1217resultsindicatepredominatelygeneticallyrenderimmunitythereforeescapeefficacyunpredictableGenetichumancytotoxicTlymphocytes

Similar Articles

Cited By